X
Xuankai Biological
Microbial-derived biostimulants and biopolymer raw materials producer
About Xuankai Biological
Nanjing Xuankai Biological Technology Co., Ltd. is a biotechnology company focused on industrial and synthetic biology for the research, development, and production of biopolymers. Founded in April 2010, the company originated from a collaboration between Nanjing Tech University and five of its academic staff: Xu Hong, Feng Xiaohai, Ouyang Pingkai, Cai Heng, and Li Sha. The company's development was built upon research from national programs, leading to the commercialization of its core products. The current de facto controllers are co-founders Xu Hong and Feng Xiaohai. Professor Xu Hong has a long-standing career in industrial biotechnology research at Nanjing Tech University, serving as the chief scientist for Jiangsu's key fermentation engineering discipline and has received numerous national and provincial science and technology awards. Feng Xiaohai also has a background as a researcher at the university and now serves as the company's general manager.
Xuankai Biological operates through R&D and production platforms focused on functional microorganisms, microbial secretions, and enzyme catalysis products. Its business model involves supplying raw materials and producing finished formulations for several markets, including plant nutrition, daily chemicals, animal nutrition, and food. The company’s main offerings are microbial-derived biostimulants, with core products like polyglutamic acid (PGA), microbial inoculants, and ε-polylysine. ε-polylysine, a key product, is a natural antimicrobial peptide produced through microbial fermentation, used as a food preservative in products like cooked rice, meats, and noodles due to its broad-spectrum activity against bacteria, yeasts, and molds. The company also develops polyglutamic acid for both agricultural and cosmetic applications. In the plant nutrition sector, Xuankai has developed the “Gu Lefeng” brand, which consists of a range of biostimulant products designed to enhance nutrient absorption and stress tolerance in crops. The company was a key participant in drafting the industry standards for cosmetic and agricultural-grade polyglutamic acid in China.
Source: Dealroom company dataNews
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2020 | $11M | $44M | Jinyu Maowu Investment · Nanjing Innovation Capital | — |
| SERIES AOther financing | Dec 2017 | $1.4M | $5.5M | Undisclosed | — |
Growth signals
Latest recorded traffic for Xuankai Biological is 1.8K monthly website visits, up 140% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Xuankai Biological in its local ecosystem
The Xuankai Biological office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- JCJinmao Capital
Series A2 investors entered at this stage
- JIJinyu Maowu Investment
- NCNanjing Innovation Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Xuankai Biological on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xuankai Biological’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.